Antibiotic Treatment Improves the Efficacy of Oxaliplatin-Based Therapy as First-Line Chemotherapy for Patients with Advanced Gastric Cancer: A Retrospective Study
Hiroo Imai, Ken Saijo, Keigo Komine, Reio Ueta, Ryunosuke Numakura, Shonosuke Wakayama, Sho Umegaki, Sakura Hiraide, Yoshufumi Kawamura, Yuki Kasahara, Kota Ohuchi, Masahiro Takahashi, Shin Takahashi, Hidekazu Shirota, Masanobu Takahashi, Chikashi Ishioka Department of Medical Oncology, Tohoku Unive...
Hauptverfasser: | Imai H, Saijo K, Komine K, Ueta R, Numakura R, Wakayama S, Umegaki S, Hiraide S, Kawamura Y, Kasahara Y, Ohuchi K, Takahashi M, Takahashi S, Shirota H, Ishioka C |
---|---|
Format: | Artikel |
Sprache: | English |
Veröffentlicht: |
Dove Medical Press
2022-03-01
|
Schriftenreihe: | Cancer Management and Research |
Schlagworte: | |
Online Zugang: | https://www.dovepress.com/antibiotic-treatment-improves-the-efficacy-of-oxaliplatin-based-therap-peer-reviewed-fulltext-article-CMAR |
Ähnliche Einträge
Ähnliche Einträge
-
Evaluation of Outcome and Tolerability of Combination Chemotherapy with Capecitabine and Oxaliplatin as First Line Therapy in Advanced Gastric Cancer
von: Mohammad Ali Mashhadi, et al.
Veröffentlicht: (2016-10-01) -
Phase II study of adjuvant chemotherapy with S1 plus oxaliplatin for Chinese patients with gastric cancer
von: Guoxiu Wang, et al.
Veröffentlicht: (2018-05-01) -
Comparison of the Efficacy of S-1 Plus Oxaliplatin or Capecitabine Plus Oxaliplatin for Six and Eight Chemotherapy Cycles as Adjuvant Chemotherapy in Patients With Stage II-III Gastric Cancer After D2 Resection
von: Yuanyuan Yu, et al.
Veröffentlicht: (2021-05-01) -
Comparison of PSOX (paclitaxel, oxaliplatin, S-1) and SOX (oxaliplatin, S-1) as postoperative adjuvant chemotherapy for stage II-III gastric cancer
von: Fei-Yu Wang, et al.
Veröffentlicht: (2025-03-01) -
A clinical prognostic scoring system for resectable gastric cancer to predict survival and benefit from paclitaxel- or oxaliplatin-based adjuvant chemotherapy
von: Qian J, et al.
Veröffentlicht: (2016-02-01)